Selected Publications

  1. Romero-Becerra, R., Zhao, Z., Nebdal, D. et al. Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool. Nat Commun 16, 10151 (2025). https://doi.org/10.1038/s41467-025-65218-9
  2. Zhi Zhao, John Zobolas, Manuela Zucknick, Tero Aittokallio. Tutorial on survival modeling with applications to omics data , Bioinformatics , Volume 40, Issue 3, March 2024, btae132. doi: 10.1093/bioinformatics/btae132
  3. Yingjia Chen, Liye He, Aleksandr Ianevski, Pilar Ayuda-Durán, Swapnil Potdar, Jani Saarela, Juho J. Miettinen, Sari Kytölä, Susanna Miettinen, Mikko Manninen, Caroline A. Heckman, Jorrit M. Enserink, Krister Wennerberg & Tero Aittokallio.  Robust scoring of selective drug responses for patient-tailored therapy selection .   Nat Protoc  19 , 60–82 (2024) doi: 10.1038/s41596-023-00903-x
  4. Zhao Z, Wang S, Zucknick M, Aittokallio T. Tissue-specific identification of multi-omics features for pan-cancer drug response prediction . iScience 2022;25:104767. doi: 10.1016/j.isci.2022.104767
  5. Ianevski A, Giri AK, Aittokallio T. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data . Nat Commun  13 , 1246 (2022). http://doi.org/10.1038/s41467-022-28803-w.
  6. Ianevski A, Lahtela J, Javarappa KK, Sergeev P, Ghimire BR, Gautam P, Vähä-Koskela M, Turunen L, Linnavirta N, Kuusanmäki H, Kontro M, Porkka K, Heckman CA, Mattila P, Wennerberg K, Giri AK, Aittokallio T.  Patient-tailored design for selective co-inhibition of leukemic cell subpopulations . Sci. Adv. 7 , eabe4038 (2021). doi: 10.1126/sciadv.abe4038
 
Scroll to top